COGSTATE LIMITED (CGS)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

CGS - COGSTATE LIMITED

FNArena Sector : Medical Equipment & Devices
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 0.08
Index: ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$1.34

15 Apr
2024

0.090

OPEN

$1.25

7.20%

HIGH

$1.34

120,629

LOW

$1.24

OTHER COMPANIES IN THE SAME SECTOR
4DX . AT1 . BRN . CAT . CBL . CMP . COH . CSX . CU6 . CYC . EBR . EMV . EYE . FPH . IDX . IME . IMR . IPD . LDX . MX1 . NAN . ONE . PCK . PEB . PGC . PME . RMD . SOM . TRJ . UBI . VHT . VTI .
FNARENA'S MARKET CONSENSUS FORECASTS

- No Record -

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx3.1
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx60.1 M
Book Value Per Share xxxxxxxxxxxxxxx32.7
Net Operating Cash Flow xxxxxxxxxxxxxxx1.8 M
Net Profit Margin xxxxxxxxxxxxxxx8.82 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx10.15 %
Return on Invested Capital xxxxxxxxxxxxxxx10.06 %
Return on Assets xxxxxxxxxxxxxxx6.38 %
Return on Equity xxxxxxxxxxxxxxx10.15 %
Return on Total Capital xxxxxxxxxxxxxxx6.37 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx1.6 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx1 M
Long Term Debt xxxxxxxxxxxxxxx0 M
Total Debt xxxxxxxxxxxxxxx1 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx43 M
Price To Book Value xxxxxxxxxxxxxxx5.05

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx3.3 M
Capex % of Sales xxxxxxxxxxxxxxx5.46 %
Cost of Goods Sold xxxxxxxxxxxxxxx48 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx9 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx-

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

0
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

CGS STOCK CHART